These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 302552)

  • 1. Antibody-dependent cell-mediated cytotoxicity by activated thymocyte populations. Nature of the effector cell(s).
    Rubin B; Hoier-Madsen M
    Acta Pathol Microbiol Scand C; 1977 Aug; 85C(4):262-76. PubMed ID: 302552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
    Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
    J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent cell-mediated cytotoxicity. Comparative ability of murine Peyer's patch and spleen cells to lyse lipopolysaccharide-coated and uncoated erythrocytes.
    Kagnoff MF; Campbell S
    Gastroenterology; 1976 Mar; 70(3):341-6. PubMed ID: 1082425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte-mediated cytotoxicity against tumor cells II. Characteristics and tissue distribution of concanavalin A-activated cytotoxic effector cells.
    Waterfield JD; Waterfield EM
    Eur J Immunol; 1976 May; 6(5):309-16. PubMed ID: 1086781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL; Lazdins JK; Hieny S; Natovitz P
    J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. II. Identification of effector cells and analysis of mechanisms.
    Gardner I; Bowern NA; Blanden RV
    Eur J Immunol; 1974 Feb; 4(2):68-72. PubMed ID: 4546746
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relationship between cytotoxic T-lymphocytes and suppressors blocking activation of DNA synthesis in mixed lymphocyte cultures].
    Khachikian EIa; Brondz BD; Drizlikh GI; Egorova SG
    Biull Eksp Biol Med; 1978 Feb; 85(2):189-92. PubMed ID: 147114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of cytotoxic t-lymphocytes eluted from allogenic target cells].
    Egorov SG; Brondz BD
    Biull Eksp Biol Med; 1977 Jan; 83(1):50-3. PubMed ID: 322755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines.
    Ralph P; Nakoinz I
    Cancer Res; 1981 Sep; 41(9 Pt 1):3546-50. PubMed ID: 6973392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis.
    Doherty PC; Zinkernagel RM; Ramshaw IA
    J Immunol; 1974 Apr; 112(4):1548-52. PubMed ID: 4592605
    [No Abstract]   [Full Text] [Related]  

  • 15. Allograft cytotoxicity. Role of T lymphocytes bearing a receptor for complement.
    Arnaiz-Villena A; Jones B; Roitt IM
    Immunology; 1975 Nov; 29(5):903-8. PubMed ID: 811554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
    Tilden AB; Itoh K; Balch CM
    J Immunol; 1987 Feb; 138(4):1068-73. PubMed ID: 3100627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The syngeneic T-T lymphocyte reaction (STTLR). II. Induction of primary T anti-T cell cytotoxic responses in vitro in T cell cultures stimulated with syngeneic self-reactive T cells.
    Suzuki H; Quintáns J
    J Mol Cell Immunol; 1986; 2(6):345-57. PubMed ID: 3509919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of mononuclear effector cells in human blood.
    Hersey P; Edwards A; Edwards J
    Clin Exp Immunol; 1976 Jan; 23(1):104-13. PubMed ID: 1083316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated cytotoxicity in vitro: target-cell recognition and effector-cell requirements.
    Perlmann P; Holm G; Stejskal V
    Transplant Proc; 1973 Dec; 5(4):1625-9. PubMed ID: 4272822
    [No Abstract]   [Full Text] [Related]  

  • 20. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection.
    Tsung K; Dolan JP; Tsung YL; Norton JA
    Cancer Res; 2002 Sep; 62(17):5069-75. PubMed ID: 12208763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.